SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001096906-22-002073
Filing Date
2022-08-31
Accepted
2022-08-31 15:58:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D - GLYCODOTS, LLC axim_sc13d.htm SC 13D 31365
  Complete submission text file 0001096906-22-002073.txt   32975
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Subject) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88107 | Film No.: 221217956
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 3904 CAMINITO SILVELA SAN DIEGO CA 92122 858-923-4422
Glycodots, LLC (Filed by) CIK: 0001944801 (see all company filings)

IRS No.: 270374258 | State of Incorp.: AZ | Fiscal Year End: 1231
Type: SC 13D